| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0.3B | $0.3B | $0.3B | $0.5B | $0.4B | $0.4B | $0.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $-0.1B | $0.1B | $0.2B | $0.6B | $0.7B | $0.4B | $0.2B | $0.1B |
| EPS (Basic) | $-0.81 | $1.20 | $1.87 | $4.54 | $4.23 | $2.14 | $0.79 | $0.28 |
| EPS (Diluted) | $-0.81 | $1.18 | $1.85 | $4.49 | $4.18 | $2.12 | $0.78 | $0.28 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $48.7B | $51.8B | $61.4B | $70.8B | $80.6B | $87.4B | $94.9B | $104.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.6B | $0.7B | $0.8B | $1.5B | $0.9B | $1.2B | $1.2B | $1.3B |
| Total Liabilities | $46.3B | $49.1B | $58.6B | $67.8B | $78.0B | $85.0B | $91.6B | $100.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.4B | — | — | $3.0B | $2.6B | $2.4B | $3.3B | $3.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.5B | $0.7B | $0.3B | $0.7B | $1.0B | $1.0B | $1.1B |
| Investing Cash Flow | $2.7B | $8.5B | $7.4B | $10.6B | $6.7B | $6.4B | $7.5B | $10.4B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-3.2B | $-9.6B | $-10.0B | $-9.7B | $-7.3B | $-7.7B | $-10.0B | $-10.9B |